Polypeptide Multilayer Nanofilms Research Articles

Programmed Multidrug Delivery Based on Bio-Inspired Capsule-Integrated Nanocoatings for Infected Bone Defect Treatment.

Infection and delayed wound healing are two major serious complications related to traumatic injuries and cause a significant burden to patients and society. Most currently available drug delivery materials typically carry a single drug, lack protection from drug loading, and face challenges in on-demand and precisely controlled drug release. Here, we report a flower (Cirsium arvense)-inspired capsule-integrated multilayer nanofilm (FICIF), synthesized using a layer-by-layer self-assembly, for programmed multiple drug co-delivery for trauma (open fracture as an example) treatments. Our approach allows polypeptide multilayer nanofilms and innovative impregnated capsules to assemble hierarchical reservoirs with specific drug binding sites, shielding protection capability, and ordered packing structures. The resultant FICIF nanocarriers enable sustained and on-demand co-delivery of a unique immune-tuning cytokine (interleukin 12p70) and a growth factor (bone morphogenetic protein 2) in clinical use, resulting in extraordinary anti-infection (3 orders of magnitude improved bacterial killing) and bone regeneration (5 times enhanced bone healing) in treating infected rat femur fractures. The successful synthesis of these biomimetic high-performance delivery nanocoatings is expected to serve as a source of inspiration for the development of biomaterials for various clinical applications.

Cefazolin embedded biodegradable polypeptide nanofilms promising for infection prevention: a preliminary study on cell responses.

Implant-associated infection is a serious complication in orthopedic surgery, and endowing implant surfaces with antibacterial properties could be one of the most promising approaches for preventing such infection. In this study, we developed cefazolin loaded biodegradable polypeptide multilayer nanofilms on orthopedic implants. We found that the amount of cefazolin released could be tuned. A high local concentration of cefazolin was achieved within the first a few hours and therefore may inhibit bacterial colonization in the critical postimplantation period. The developed cefazolin loaded nanofilms showed their in vitro efficacy against Staphylococcus aureus; the more antibiotics loaded, the longer the nanocoated implant had antibacterial properties. More interestingly, antibiotic-loaded polypeptide multilayer nanofilms also improved osteoblast bioactivity including cell viability and proliferation. These findings suggested that biodegradable polypeptide multilayer nanofilms as antibiotic carriers at the implant/tissue interface are compatible with human cells such as osteoblasts and bactericidal to bacteria such as S. aureus. These characteristics could be promising for preventing implant-associated infection and potentially improving bone healing.

Present and Future Prospects for Polypeptide Multilayer Nanofilms in Biotechnology and Medicine

Polypeptide multilayer nanofilms are a promising nanotechnology for commercial product development because the processes used to prepare them are simple, flexible, reliable, automatable, and scalable. Moreover, these materials can display a remarkable diversity of physical, chemical, and biological properties. Furthermore, the constituents of these nanofilms, in most cases the nanofilms themselves, and the fabrication process are environmentally benign. Nanofilm structure and function can be tailored to address two Grand Challenges of the US National Nanotechnology Initiative.

Tunable drug loading and release from polypeptide multilayer nanofilms.

Polypeptide multilayer nanofilms were prepared using electrostatic layer-by-layer self-assembly nanotechnology. Small charged drug molecules (eg, cefazolin, gentamicin, and methylene blue) were loaded in polypeptide multilayer nanofilms. Their loading and release were found to be pH-dependent and could also be controlled by changing the number of film layers and drug incubation time, and applying heat-treatment after film formation. Antibioticloaded polypeptide multilayer nanofilms showed controllable antibacterial properties against Staphylococcus aureus. The developed biodegradable polypeptide multilayer nanofilms are capable of loading both positively- and negatively-charged drug molecules and promise to serve as drug delivery systems on biomedical devices for preventing biomedical device-associated infection, which is a significant clinical complication for both civilian and military patients.

Reversibility of Structural Changes of Polypeptides in Multilayer Nanofilms

Structural properties of different polypeptide multilayer nanofilms fabricated at neutral pH have been analyzed by UV spectroscopy, circular dichroism spectroscopy (CD), and Fourier-transform infrared spectroscopy (FTIR). The various peptides studied exhibit a strong tendency to adopt a beta sheet conformation in the films. Changes in film structure on dehydration are completely reversed on rewetting. The time scale of reversibility is, however, substantially shorter for the polymer backbone than the side chains, as in protein folding.

Context Dependence of the Assembly, Structure, and Stability of Polypeptide Multilayer Nanofilms

Polyelectrolyte multilayer nanofilms and nanocomposites have shown considerable promise for the rational development of multifunctional materials with wide-ranging properties. Polypeptides are a distinctive and largely unexplored class of polyelectrolytes in this context. Methods now exist for the synthesis of peptides with control at the level of the amino acid sequence, and for the preparation of these polymers in massive quantities. Here, we analyze the roles of six designed 32mer peptides in the fabrication, structure, and stability of multilayer nanofilms prepared by layer-by-layer self-assembly. The data show that amino acid sequence and the specific combination of anionic and cationic peptides together have a marked impact on nanofilm growth behavior, secondary structure content, and density in experimental studies. The same factors determine physical properties of the corresponding interpolypeptide complexes in molecular dynamics simulations.

Applications of polypeptide multilayer nanofilms in vitro and in vivo

Applications of polypeptide multilayer nanofilms in vitro and in vivo

Controlled loading and release of a model drug from polypeptide multilayer nanofilms

A major concern of medicine today is the sustained release of therapeutic compounds. Delivery vehicles for such compounds must be biocompatible. Ideally, loading a drug into the delivery vehicle will be a simple process, and vehicle properties will allow control over the drug release profile under desired conditions. Here, polypeptide multilayer nanofilms have been prepared by electrostatic layer-by-layer self-assembly to study the post-fabrication loading and release of a model therapeutic, methylene blue (MB). Drug loading and release have been characterized by optical spectroscopy for different peptide designs at different pH values, and film surface morphology has been characterized by atomic force microscopy (AFM). Differences in peptide structure have been found to influence MB loading and release under otherwise fixed conditions. Release is also influenced by pH, salt concentration, and number of “capping” layers. Although more research will be needed to exhaust the potential of polypeptide multilayer films, present results would suggest that the technology holds considerable promise for applications in medicine.

Internal Structure of Wet and Dry Polypeptide Multilayer Nanofilms

Internal Structure of Wet and Dry Polypeptide Multilayer Nanofilms

Polypeptide multilayer nanofilms: science, technology and medicine

Polypeptide multilayer nanofilms: science, technology and medicine

Study of designed polypeptide multilayer nanofilms for controlled drug release

Study of designed polypeptide multilayer nanofilms for controlled drug release

Control of stability of polypeptide multilayer nanofilms by quantitative control of disulfidebond formation

The crosslinking of polymers in a polymeric material will alter the mechanical properties ofthe material. Control over the mechanical properties of polyelectrolyte multilayer films(PEMs) could be useful for applications of the technology in medicine and other areas.Disulfide bonds are ‘natural’ polypeptide crosslinks found widely in wild-type proteins.Here, we have designed and synthesized three pairs of oppositely charged 32merpolypeptide to have 0, 4, or 8 cysteine (Cys) residues per molecule, and we havecharacterized physical properties of the peptides in a PEM context. The average lineardensity of free thiol in the designed peptides was 0, 0.125, or 0.25 per amino acid residue.The peptides were used to make 10-bilayer PEMs by electrostatic layer-by-layerself-assembly (LBL). Cys was included in the peptides to study specific effects of disulfidebond formation on PEM properties. Features of film assembly have been found todepend on the amino acid sequence, as in protein folding. Following polypeptideself-assembly into multilayer films, Cys residues were disulfide-crosslinked undermild oxidizing conditions. The stability of the crosslinked films at acidic pH hasbeen found to depend on the number of Cys residues per peptide for a givencrosslinking procedure. Crosslinked and non-crosslinked films have been analysed byultraviolet spectroscopy (UVS), ellipsometry, and atomic force microscopy (AFM) tocharacterize film assembly, surface morphology, and disassembly. A selective etchingmodel of the disassembly process at acidic pH is proposed on the basis of theexperimental data. In this model, regions of film in which the disulfide bonddensity is low are etched at a higher rate than regions where the density is high.

Polypeptide multilayer nanofilm artificial red blood cells

Reliable encapsulation of hemoglobin (Hb) within polypeptide multilayer nanofilms has been achieved by a template-based approach, and protein functionality has been demonstrated postencapsulation. The method is general in scope and could be useful for many other encapsulants. Met-Hb was adsorbed onto 5 microm-diameter CaCO3 microparticles, and the Hb-coated particles were encapsulated within a multilayer nanofilm of poly(L-glutamic acid) (PLGA) and poly(L-lysine) (PLL) by layer-by-layer assembly. The CaCO3 templates were then dissolved within the PLGA/PLL nanofilms by addition of ethylenediaminetetraacetic acid. Encapsulation of Hb was proved by fluorescence microscopy, the pH-dependence of retention of Hb was determined by visible wavelength absorbance, and conversion of the encapsulated met-Hb to deoxy-Hb and oxy-Hb was demonstrated by spectroscopic analysis of the Soret absorption peak under various conditions. It thus has been shown that control of Hb oxygenation within polypeptide multilayer nanofilm artificial cells is possible, and that Hb thus encapsulated can bind, release, and subsequently rebind molecular oxygen. This work therefore represents an advance in the development of polypeptide multilayer film artificial red blood cells.

Quantal Self-Assembly of Polymer Layers in Polypeptide Multilayer Nanofilms

Simple molecular models predict key aspects of the "microscopic" assembly behavior of various peptide systems in the fabrication of multilayer films. Such films show substantial differences in density for different peptide systems. The data suggest that exponential film growth is possible in the absence of polymer diffusion and that "macroscopic" assembly behavior is more a function of peptide-peptide interactions than peptide sequence alone.

Antimicrobial polypeptide multilayer nanocoatings

A multilayer coating (or film) of nanometer-thick layers can be made by sequential adsorption of oppositely charged polyelectrolytes on a solid support. The method is known as layer-by-layer assembly (LBL). No special apparatus is required for LBL and nanofilms can be prepared under mild, physiological conditions. A multilayer nanofilm in which at least one of the constituent species is a polypeptide is a polypeptide multilayer nanofilm. The present work was aimed at assessing whether polypeptide multilayer nanofilms with specific antimicrobial properties could be prepared by incorporation of a known antimicrobial agent in the film structure, in this case the edible protein hen egg white lysozyme (HEWL). The chicken enzyme is widely employed as a human food preservative. An advantage of LBL in this context is that the nanofilm is fabricated directly on the surface of interest, eliminating the need to incorporate the antimicrobial in other packaging materials. Here, nanofilms were made of poly(L-glutamic acid) (PLGA), which is highly negatively charged in the mildly acidic pH range, and HEWL, which has a high net positive charge at acidic pH. We show that PLGA/HEWL nanofilms inhibit growth of the model microbe Microccocus luteus in the surrounding liquid medium. The amount of HEWL released from PLGA/HEWL films depends on the number of HEWL layers and therefore on the total quantity of HEWL in the films. This initial study provides a sketch of the scope for further development of LBL in the area of antimicrobial polypeptide multilayer films. Potential applications of such films include strategies for food preservation and coatings for implant devices.